D.E. Shaw & Co’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $73.4M | Buy |
5,728,177
+397,113
| +7% | +$5.06M | 0.06% | 500 |
|
|
2025
Q4 | $47.9M | Buy |
5,331,064
+3,102,664
| +139% | +$42.7M | 0.04% | 727 |
|
|
2025
Q3 | $38.5M | Buy |
2,228,400
+1,403,673
| +170% | +$17.3M | 0.03% | 791 |
|
|
2025
Q2 | $7.74M | Buy |
824,727
+792,331
| +2,446% | +$6.51M | 0.01% | 1696 |
|
|
2025
Q1 | $230K | Sell |
32,396
-1,187
| -4% | -$12K | ﹤0.01% | 3877 |
|
|
2024
Q4 | $392K | Buy |
33,583
+21,303
| +173% | +$332K | ﹤0.01% | 3759 |
|
|
2024
Q3 | $252K | Buy |
+12,280
| New | +$283K | ﹤0.01% | 4062 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 4777 |
|
|
2023
Q1 | – | Sell |
-15,152
| Closed | -$529K | – | 4761 |
|
|
2022
Q4 | $529K | Sell |
15,152
-36,419
| -71% | -$1.73M | ﹤0.01% | 3825 |
|
|
2022
Q3 | $2.89M | Sell |
51,571
-374,779
| -88% | -$23.2M | 0.01% | 2676 |
|
|
2022
Q2 | $22.1M | Buy |
426,350
+207,941
| +95% | +$10.6M | 0.04% | 802 |
|
|
2022
Q1 | $15.9M | Buy |
218,409
+215,775
| +8,192% | +$18.3M | 0.02% | 1198 |
|
|
2021
Q4 | $311K | Sell |
2,634
-7,398
| -74% | -$927K | ﹤0.01% | 4662 |
|
|
2021
Q3 | $1.35M | Sell |
10,032
-104,960
| -91% | -$15.9M | ﹤0.01% | 3371 |
|
|
2021
Q2 | $18.6M | Sell |
114,992
-288,728
| -72% | -$22.5M | 0.02% | 1064 |
|
|
2021
Q1 | $32.4M | Buy |
403,720
+42,349
| +12% | +$2.84M | 0.04% | 681 |
|
|
2020
Q4 | $19.7M | Buy |
361,371
+189,402
| +110% | +$6.88M | 0.02% | 964 |
|
|
2020
Q3 | $3.42M | Sell |
171,969
-22,492
| -12% | -$469K | ﹤0.01% | 1973 |
|
|
2020
Q2 | $4.09M | Buy |
+194,461
| New | +$3.3M | 0.01% | 1805 |
|
|
2020
Q1 | – | Sell |
-12,625
| Closed | -$185K | – | 4173 |
|
|
2019
Q4 | $185K | Buy |
+12,625
| New | +$176K | ﹤0.01% | 3819 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
